Hopper D G, Pimm M V, Baldwin R W
Br J Cancer. 1975 Feb;31(2):176-81. doi: 10.1038/bjc.1975.23.
Subcutaneous growth of immunogenic chemically induced rat sarcomata and a hepatoma was restricted when cells were injected into syngeneic animals in admixture with MER. Rats rejecting mixed inocula were immune to further challenge with the same tumour. Growth of a chemically induced mammary carcinoma which lacks detectable immunogenicity was suppressed when low cell inocula were injected in admixture with MER or intact BCG organisms, although animals were not immune to re-challenge. These studies indicate that clinically MER may be a suitable alternative to BCG for contact suppression of tumour growth or incorporation into tumour cell:adjuvant vaccines for active immunotherapy.
当将细胞与MER混合注射到同基因动物体内时,免疫原性化学诱导大鼠肉瘤和肝癌的皮下生长受到限制。排斥混合接种物的大鼠对同一肿瘤的进一步攻击具有免疫力。当低细胞接种物与MER或完整的卡介苗混合注射时,缺乏可检测免疫原性的化学诱导乳腺癌的生长受到抑制,尽管动物对再次攻击没有免疫力。这些研究表明,在临床上,MER可能是卡介苗的合适替代品,用于接触抑制肿瘤生长或纳入肿瘤细胞:佐剂疫苗进行主动免疫治疗。